Institutional investors purchased a net $295.9 thousand shares of LIFE during the quarter ended March 2016 and now own 52.28% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GRUSS CAPITAL MANAGEMENT LP Bought 600.0 Thousand shares of aTyr Pharma Inc